UPDATE 2-Bristol raises 2016 forecast after earnings beat

April 28 (Reuters) - Bristol-Myers Squibb Co

ratcheted up its 2016 profit view after trouncing first-quarter

sales and earnings forecasts on strong demand for its new Opdivo

immuno-oncology drug and Eliquis blood clot preventer.

Read more